Cell Therapy

All articles by Cell Therapy

Gilead’s Kite expands Arcellx deal with $285M investment
Gilead’s Kite expands Arcellx deal with $285M investment
Lecia Bushak
November 15, 2023
3:37 pm

Kite Pharma will build on its previous collaboration with Arcellx to pick up ACLX-001, a BCMA-targeted CAR-T cell therapy for multiple myeloma.

Novo Nordisk eyes cell therapies for treating diabetes, obesity
Novo Nordisk eyes cell therapies for treating diabetes, obesity
Jack O'Brien
April 12, 2023
10:32 am

The agreement, worth up to $2.6B, indicates that Novo Nordisk plans on expanding its reach in the diabetes and obesity space.

Regeneron, Sonoma Biotherapeutics ink $75M collaboration to develop novel T cell therapies
Regeneron, Sonoma Biotherapeutics ink $75M collaboration to develop novel T cell therapies
Jack O'Brien
March 28, 2023
10:24 am

From a financial perspective, Sonoma will receive a $30 million equity investment from Regeneron, $45 million in cash and is eligible to receive a $45 million development milestone payment. 

Sonata Therapeutics hires former Kite exec Francesco Marincola as chief scientific officer
Sonata Therapeutics hires former Kite exec Francesco Marincola as chief scientific officer
Lecia Bushak
March 21, 2023
1:34 pm

Marincola previously served as SVP and global head of cell therapy research at Kite Pharma.

Sanofi gains license to Innate’s NK cell therapeutics program
Sanofi gains license to Innate’s NK cell therapeutics program
Lecia Bushak
December 19, 2022
11:37 am

The $26.6 million deal further expands the companies’ partnership in developing natural killer cell therapies.

Bone Therapeutics rebrands as BioSenic
Bone Therapeutics rebrands as BioSenic
Lecia Bushak
October 27, 2022
12:11 pm

The new name is meant to reflect the company’s recent acquisition of Medsenic.

Allogene Therapeutics debuts CAR T Together to expand treatment access
Allogene Therapeutics debuts CAR T Together to expand treatment access
Jack O'Brien
October 11, 2022
11:20 am

A recent survey found that only half of eligible cancer patients receive CAR T therapy treatments.

  • From Our Partners